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Abstract
Introduction: Polymorphism of the gene encoding α-1 chain of type I collagen (COL1A1) may influence the
mechanical properties of the pelvic floor connective tissue. 
Aim of study: We examined possible role of G→T substitution in transcription factor Sp1 binding site in the gene
encoding α-1 chain of type I collagen (COL1A1) in the development of pelvic organ prolapse. 
Materials and methods: The study group consisted of 37 women with pelvic floor defects graded according POPQ
scale as stage II, III and IV. All study group patients underwent reconstructive surgery of the pelvic floor. We enrolled
forty control subjects. All of them were treated for benign gynecological conditions other then stress urinary incon-
tinence or pelvic organ prolapse. DNA was obtained from peripheral blood leukocytes. The fragment of the first
intron of COL1A1 gene containing Sp1 binding site was amplified by PCR and analysis of restriction fragment length
polymorphism was done. 
Results: The GG polymorphism in COL1A1 gene was identified in 26 (70.3%), GT sequence in 10 (27%) and TT in
1 (2.7%) patient. The distribution of the investigated polymorphisms in the control group were: 27 (67.5%), 9
(22.5%) and 4 (10%), respectively. We do not found association between investigated polymorphic variants and
pelvic organ prolapse (chi2 test, p=ns). 
Conclusion: G→T substitution in transcription factor Sp1 binding site in the COLIA1 gene does not increase the risk
of development of pelvic floor defect (POPQ stages II, III, IV). 
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Introduction
Pelvic organ prolapse is common condition with great
influence on women's quality of life. It is estimated that 41%
women with intact uterus develop some form of prolapse, with
34.3% having cystocele, 14.2% having uterine prolapse, and
18.6% having rectocele. Similar prevalence of pelvic floor
defect is reported in hysterectomized women [1]. 
Overall lifetime risk of surgery because of prolapse is
11.1%. What is more, nearly 30% of surgically treated women
require futher operation for the same or other pelvic floor
defect [2]. The known risk factors for pelvic organ prolapse are
vaginal birth, advanced age, obesity, cigarette smoking, chron-
ic cough and previous hysterectomy [3, 4]. 
There are also data suggesting existence of familial predis-
position for the development of this condition. This phenom-
enon may be explained by genetically inherited disturbances in
connective tissue metabolism. This view is further supported
by the results of previous study showed that the development
of stress urinary incontinence (SUI) in women may be related
to the diminished content of type I colagen in the pelvic floor
connective tissue [5]. It has been postulated that the changes in
the quantity and the quality of collagen may be involved in the
pathogenesis of pelvic organ prolapse. One of the most inten-
sively studied is the single-nucleotide polymorphism in the
promoter region of first intron of COL1A1 gene. Recent data
suggest that substitution of guanidine for the thymidine
residue (G→T) at position 1240 in the first intron of COL1A1
gene can affect rate of its expression [6].  
As a result three different genotypes exist i.e. homozygotes
G/G, heterozygotes G/T and homozygotes T/T. These varia-
tions are of importance because affect a recognition site for
the transcription factor Sp1 and thus are able to influence
COL1A1 gene expression [7]. 
The clinical effect of Sp1 COL1A1 polymorphism is
reduced mechanical strength of the connective tissue in
G/T and especially in T/T individuals in comparison to
G/G subjects. 
Aim of the study 
We checked hypothesis that the polymorphism in the tran-
scription factor Sp1 binding site of gene encoding α-1 chain of
collagen type I predisposes for the development of pelvic
organ prolapse in women.
Material and methods
Study protocol was approved by Institutional Ethics Com-
mittee. All participants gave written informed consent. Thirty
seven women presenting pelvic organ prolapse  were included
into study group. Detailed medical history was taken from
each patient. The estimation of the of the defect was estab-
lished during gynecological exmination. The severity of pro-
lapse was graded according to POPQ scale [8]. 
Only patients with stages II, III and IV were included into
the study group. Hysterectomized women, patients with neu-
rological disorders, immobile or patients presenting symptoms
suggesting stress, mixed or urge urinary incontinence were
excluded from the study. The control group consisted of 40
women admitted to hospital and treated for benign gyneco-
logic conditions. Vast majority of these patients had uterine
myomas and underwent abdominal supracervical hysterecto-
my. All subjects were assessed with the same diagnostic work-
up as the study group. None of them reported symptoms of
urinary incontinence or presented significant impairment
(more then stage I in POPQ scale) of pelvic organ support.
Demographic and clinical characteristics of enrolled
patients are given in Table I. 
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Streszczenie
Wst´p: Polimorfizm genu kodujàcego ∏aƒcuch α-1 kolagenu typu I (COL1A1) mo˝e mieç wp∏yw na w∏aÊciwoÊci
mechaniczne tkanki ∏àcznej, z której zbudowane sà powi´zie dna miednicy mniejszej.  
Cel badania: Celem badania by∏o ustalenie, czy istnieje zwiàzek mi´dzy typami polimorfizmu miejsca wiàzania czyn-
nika transkrypcyjnego Sp-1 genu dla COL1A1 a ryzykiem wystàpienia defektów statyki narzàdów dna miednicy
mniejszej.
Materia∏ i metodyka: Grupa badana liczy∏a 37 pacjentek hospitalizowanych z powodu zaburzeƒ statyki okreÊla-
nych w skali POPQ jako stopieƒ II, III lub IV. Pacjentki zosta∏y poddane leczeniu chirurgicznemu korygujàcemu zabu-
rzenia statyki narzàdu p∏ciowego. Grupa kontrolna: 40 kobiet ze schorzeniami nienowotworowymi, bez zaburzeƒ
statyki (stopieƒ 0, I POPQ) i nietrzymania moczu. Od ka˝dej pacjentki pobrano 5 ml krwi, z której izolowano DNA.
Nast´pnie przeprowadzano reakcj´ amplifikacji z u˝yciem specyficznych dla badanego miejsca genomu starterów
(fragment pierwszego intronu genu COL1A1). 
Wyniki: Polimorfizm genu COL1A1 typu GG zidentyfikowano u 26 (70,3%), GT u 10 (27%), zaÊ TT u 1 (2,7%) pa-
cjentki. W grupie kontrolnej dystrybucja polimorfizmów by∏a nast´pujàca: GG 27 (67,5%), GT 9 (22,5%) TT 4 (10%).
Nie wykazano istotnych ró˝nic w cz´stoÊci wyst´powania typów polimorfizmu mi´dzy porównywanymi grupami
(chi2 test, p=ns). 
Wnioski: Wyniki wskazujà, ˝e substytucja typu G→T w obr´bie miejsca wiàzania czynnika transkrypcyjnego Sp-1
zlokalizowanego w obr´bie promotora genu COL1A1 nie wp∏ywa na ryzyko wystàpienia defektu statyki narzàdu
rodnego (POPQ II, III, IV).
S∏owa kluczowe: zaburzenia statyki narzàdu p∏ciowego / polimorfizm genu kodujàcego /
/ kolagen typu I / tkanka ∏àczna /
Blood samples were taken into tubes containing anticoag-
ulant EDTA. Genomic DNA was extracted from whole blood
leukocytes using commercially available kit (GenomicPrep
Blood DNA Isolation Kit, Amersham Biosciences, USA).
DNA was stored at -20°C until used. Determination of
COLIA1 polymorphism was done by PCR (Biometra T per-
sonal Thermocycler, Whatman Biometra, Germany) using
400 ng DNA. For amplification, the Taq DNA polymerase
(Promega, Madison, WI, USA) and commercially obtained
oligonucleotide primers were used (Serwis Sekwencjonowania
i Syntezy DNA IBB PAN). 
The first step PCR was carried out with the following
primers set: 
5’- GGAAGACCCGGGTTATTGCT - 3’ (forward) and 
5’- CGCTGAAGCCAAGTGAAATA - 3’ (reverse) [9]. 
The 35 amplification cycles were preceded by denaturation
at 99°C for 10 min. Annealing was carried out at 57°C for
1min, elongation at 72°C for 1min, and denaturation
94.5°C for 1min. A final primer extension was carried out at
72°C for 10min. The final recognition of Sp1 site was based on
analysis of a restriction fragment length polymorphism
(RFLP). 
PCR products (598 bp) underwent digestion with
Van91I with subsequent separatation on 2% agarose gel. The
sequence recognized by Van91I (5'-CCANNNN/NTGG-3')
enables to identify nucleotide G in Sp1 polymorphic site. 
Single band 598 bp corresponds to homozygote TT, three
bands 598, 430 and 168 bp heterozygote GT and two bands
430, 168 bp enables to identify homozygote TT (Figure 1).
The chi2 test was used for the comparison of the genotypes
prevalence between pelvic prolapse group and control
patients. Because the distribution of age, parity and body
mass index were skewed, differences in means and median
were tested with the Mann-Whitney test. The influence of
genotype on the risk of SUI was estimated by calculation of
odds ratios and 95% confidence intervals. All statistics were
performed with Statistica v.6.1 (StatSoft, USA).
Results
The compared groups were well matched with regard to
demographic and clinical characteristics. In the study group
the GG polymorphism in COL1A1 gene was identified in 26
(70.3%), GT sequence in 10 (27%) and TT in 1 (2.7%) patient.
The distribution of the investigated polymorphisms in the
control group were: 27 (67.5%), 9 (22.5%) and 4 (10%), respec-
tively. The statistical analysis (chi2 test) did not show any sig-
nificant differences between compared groups (p=ns). 
Discussion
Analysis of clinical data showed that majority of parous
women do not have pelvic organ prolapse, while this distur-
bance may occur in nulliparous women. There is also the evi-
dence suggesting that genetic factors may play a role in the
development of pelvic organ support failure in women. Jack et
al. estimated risk of this defect in sisters with stage III and IV
prolapse as 5 times greater then in general population [10].  
Interesting results brought the study based on comparison
of the occurence of pelvic floor defects within pairs of bio-
logical sisters, one of them parous, the other nulliparous.
Authors found high concordance of pelvic organ prolapse in
compared relatives. This finding indicates the existence of
familial and inherited predisposition for the development of
this disturbance [11].
Data linking genetic factors with the biomechanical
impairment of pelvic floor support do not uncover pathogen-
esis of the defect. Based on findings of previous study which
shed some light on genetic causes of SUI we proposed that
similar  mechanism may exist in the cases of pelvic organ pro-
lapse [12]. 
However, in this study we did not found the association
between COL1A1 gene transcription factor Sp1 binding site
polymorphism and a risk of development of pelvic organ pro-
lapse. This is in contrast to established link between GT and
especially TT sequence in the Sp1 polymorphic site and
incresed risk of SUI. The explanation of this finding is possi-
ble difference of pathogenesis of pelvic floor defects and SUI.
However, the vast majority of clinical data suggest close links
between SUI and pelvic organ prolapse. Due to complexity of
connective tissue metabolism the involvement of other genet-
ic factors in the development of pelvic organ prolapse is also
possible. 
854 N r  1 1 / 2 0 0 7
P R A C E O R Y G I N A L N E
g ineko l og ia
Ginekol Pol. 2007, 78, 852-855
Polymorphism of the gene encoding alfa-1 chain of collagen type I and a risk of pelvic organ prolapse...
Figure 1. Representative gel showing restriction fragments after 
digestion of the PCR products with Van91I. 
Lane 1 molecular weight markers; lane 2 heterozygote G/T; 
lane 3 homozygote G/G; lane 4 homozygote T/T.
Table I. Demographic and clinical characteristics of study and control
group
Characteristic
Mean (SD) age, y
Mean (SD) body mass
index (kg/m2)
Median (range) parity
Premenopausal
Postmenopausal
Women with pelvic
organ prolapse 
(n = 37)
57.1 (9,3)
27.5 (4,8)
2.6 (0-6)
26
14
Control 
group     
(n = 40)
54 (9,4)
27.9 (5,1)
2.4 (0-6)
18
19
p
0.2
0.8
0.5
0.2
Nikolova and co-workers suggest that the polymorphism
of the promoter of laminin gamma1 (LAMC1) may increase
risk of early-onset pelvic organ prolapse. Also, it is necessary
to remember that pelvic floor defects  are disturbances in
which genetics plays probably minor role compared to envi-
ronmental factors [13]. 
The main limitation of this study is number of enrolled
patients. Much larger sample is necessary to obtain conclusive
results regarding the role of Sp1 COL1A1 polymorphism in
the development of pelvic organ prolapse. 
Conclusion
G→T substitution in transcription factor Sp1 binding site
in the COL1A1 gene does not increase the risk of develop-
ment of pelvic floor defect (POPQ stages II, III, IV).
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